LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER (FMF) - INTERIM ANALYSIS OF THE RELIANCE REGISTRY

Henes J, Kuemmerle-Deschner JB, Krickau T, Kallinich T, Dressler F, Horneff G, Meier F, Foeldvari I, Weller-Heinemann F, Kortus-Goetze B, Hufnagel M, Rech J, Oommen P, Weber-Arden J, Blank N (2022)


Publication Type: Conference contribution

Publication year: 2022

Journal

Publisher: BMJ PUBLISHING GROUP

City/Town: LONDON

Pages Range: 29-30

Conference Proceedings Title: ANNALS OF THE RHEUMATIC DISEASES

DOI: 10.1136/annrheumdis-2022-eular.4839

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Henes, J., Kuemmerle-Deschner, J.B., Krickau, T., Kallinich, T., Dressler, F., Horneff, G.,... Blank, N. (2022). LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER (FMF) - INTERIM ANALYSIS OF THE RELIANCE REGISTRY. In ANNALS OF THE RHEUMATIC DISEASES (pp. 29-30). LONDON: BMJ PUBLISHING GROUP.

MLA:

Henes, J., et al. "LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER (FMF) - INTERIM ANALYSIS OF THE RELIANCE REGISTRY." Proceedings of the ANNALS OF THE RHEUMATIC DISEASES LONDON: BMJ PUBLISHING GROUP, 2022. 29-30.

BibTeX: Download